Avadel Pharmaceuticals (AVDL) Change in Receivables (2016 - 2020)
Historic Change in Receivables for Avadel Pharmaceuticals (AVDL) over the last 6 years, with Q3 2020 value amounting to -$5.7 million.
- Avadel Pharmaceuticals' Change in Receivables fell 29336.56% to -$5.7 million in Q3 2020 from the same period last year, while for Jun 2021 it was -$5.7 million, marking a year-over-year decrease of 2702.52%. This contributed to the annual value of $22.0 million for FY2024, which is 8172.35% up from last year.
- According to the latest figures from Q3 2020, Avadel Pharmaceuticals' Change in Receivables is -$5.7 million, which was down 29336.56% from -$3.1 million recorded in Q2 2020.
- Over the past 5 years, Avadel Pharmaceuticals' Change in Receivables peaked at $5.9 million during Q3 2016, and registered a low of -$9.3 million during Q4 2017.
- Moreover, its 5-year median value for Change in Receivables was -$445000.0 (2019), whereas its average is -$379368.4.
- In the last 5 years, Avadel Pharmaceuticals' Change in Receivables skyrocketed by 31606.16% in 2016 and then plummeted by 47842.02% in 2017.
- Over the past 5 years, Avadel Pharmaceuticals' Change in Receivables (Quarter) stood at $2.5 million in 2016, then plummeted by 478.42% to -$9.3 million in 2017, then surged by 117.29% to $1.6 million in 2018, then plummeted by 127.69% to -$445000.0 in 2019, then tumbled by 1179.1% to -$5.7 million in 2020.
- Its Change in Receivables was -$5.7 million in Q3 2020, compared to -$3.1 million in Q2 2020 and $517000.0 in Q1 2020.